Study Finds Large Gap in Breast Cancer Treatment Recommendations for Patients Aged 70 vs 69
February 8th 2023Age-based heuristics can lead to large differences in breast cancer treatment based on small differences in chronologic age, according to a new analysis of more than 500,000 patient records.
Read More
Yale Scientists Develop Precision Medicine Approach to Metabolic Therapy for Breast Cancer
June 10th 2022Scientists at Yale Cancer Center have found that patients with breast cancer and high levels of insulin in the blood may be responsive to metabolism-targeting treatments, which in turn may improve the effectiveness of subsequent chemotherapy treatments.
Read More
Combination Immunotherapy Improves Outcomes for Patients with Non-small Cell Lung Cancer
May 20th 2022The phase 2 clinical trial of a multi-center study known as the COAST clinical trial has demonstrated improved outcomes using immunotherapy combinations for patients with unresectable stage III non–small cell lung cancer.
Read More
Yale Findings Broaden the Repertoire of Cancer-Relevant Genes
May 11th 2022Following an analysis of over 12,000 human genes, research from Yale Cancer Center indicates there is cancer-relevant importance in a much larger proportion of human genes than current cancer research models suggest.
Read More
‘Decision Switch’ Discovered in Mutations Linked to Common Brain Tumor
April 8th 2022Researchers at the Yale Cancer Biology Institute have clarified the role of a recurring cancer-associated tumor mutation in glioblastoma multiforme, the most common and most aggressive type of malignant brain tumor.
Read More
New Class of Oncogenic Fusions Revealed in Lung and Pancreatic Cancer
March 24th 2022A Yale Cancer Center research team has identified novel oncogenic gene fusions in lung and pancreatic cancer, as well as sarcoma. The fusions involve RASGRF1 (an activator of RAS signaling) and promote cellular changes leading to tumor development.
Read More